On the other hand, a recent systematic review comparing liquid biopsy and tissue biopsy with NGS analysis in NSCLC, showed that for BRAF mutation the positive percent agreement was inferior to 60%, probably due to the small size of cases [165]. Here, BRAF is linked to non-small cell lung carcinoma.